January 2021 FDA Recall Testosterone Cypionate by Sun Pharmaceutical Industries Inc
D-0242-2021 - Incorrect Labeling

This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on January 11, 2021 for the product Testosterone Cypionate. The FDA reported the reason for recall as incorrect labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0242-2021

Reason for Recall
Incorrect Labeling: Incorrect lot number on secondary packaging
Initiated
01-11-2021
Reported
02-03-2021
Quantity
36,275 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
SUN PHARMACEUTICAL INDUSTRIES INC
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40

Batch or Lot Expiration Information

Lot# Lot JKX2553A